Navigation Links
Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
Date:10/30/2007

n 2007 to be $1,400,000 per month and we believe our existing capital resources are adequate to fund our current plans for research and development activities well into 2009. Factors that will affect our anticipated monthly burn rate include, but are not limited to, the number of manufacturing runs required to supply our clinical trial program and the cost of each run, additional activities reducing our economic dependence on a single supplier, the number of clinical trials ultimately approved, the timing of patient enrollment in the approved clinical trials, the actual costs incurred to support each clinical trial, the number of treatments each patient will receive, the timing of the NCI's R&D activity, and the level of pre-clinical activity undertaken.

In the event that we choose to seek additional capital, we will look to fund additional capital requirements primarily through the issue of additional equity. We recognize the challenges and uncertainty inherent in the capital markets and the potential difficulties we might face in raising additional capital. Market prices and market demand for securities in biotechnology companies are volatile and there are no assurances that we will have the ability to raise funds when required.

Capital Expenditures

We spent $586,124 on intellectual property during the nine month period ending September 30, 2007 compared to $552,319 during the nine month period ending September 30, 2006. The change in intellectual property expenditures reflects the timing of filing costs associated with our expanded patent base. As well, we have benefited from a stronger Canadian dollar as our patent costs are typically incurred in U.S. currency. In the third quarter of 2007, two U.S. patents were issued bringing our total patents issued to 23 in the U.S. and six in Canada.

Investing Activities

Under our Investment Policy, we are permitted to invest in short-term instruments with a rating no less than R-1 (DBRS) with
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014  WIRB-Copernicus Group (WCG), the world,s largest ... clinical research, announced today that its Western Institutional ... by the Association for the Accreditation of Human ... safeguards for clinical research participants. WCG ... Ph.D., commented, "It is of utmost importance to ...
(Date:9/22/2014)... Mass. , Sept. 22, 2014 ... GEVA ), a biopharmaceutical company developing therapeutic ... of Robert Bazemore as Chief Operating ... , President and Chief Executive Officer, Robert will ... company,s lead program, sebelipase alfa for LAL Deficiency, ...
(Date:9/21/2014)... For the first time, scientists have discovered how to ... strength and stiffness greater than that of today,s strongest ... a research team led by John V. Badding, a ... published in the 21 September 2014 issue of the ... point of view, our discovery is intriguing because the ...
(Date:9/20/2014)... September 20, 2014 HealthTronics, ... and interventional radiology products and services, has signed ... with Clinicon Corporation for its high ... portfolio of minimally invasive, mobile, surgical technology—offering more ... Under the agreement, HealthTronics will make available Clinicon’s ...
Breaking Biology Technology:Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3
... - In an effort to spur growth in ... Wisconsin-Whitewate r graduates, the city of Whitewater ... UW-Whitewater are developing a business incubator, according to a ... which last year received a $10,000 state grant to ...
... where I served as a judge for an industry award contest. ... were locked in a conference room at the Sheraton at ... diligently selected the winners of this year's Medical Design Excellence ... much more recognition, the MDEA winners may very well save your ...
... Corp. has signed a definitive agreement to acquire ... in Quebec City, Canada. , ,Terms of the deal ... close by the end of February. , ,RedPrairie, ... will operate under the RedPrairie name, and RedPrairie's Global ...
Cached Biology Technology:And the winners in medical design are 2And the winners in medical design are 3And the winners in medical design are 4And the winners in medical design are 5And the winners in medical design are 6
(Date:9/22/2014)... will gather in Vancouver, British Columbia, Canada, to present ... Annual Meeting & Exposition on 19-22 October 2014. Special ... crude oil, earthquake prediction problems, and how to land ... of Life on an Active Subduction Zone, details field ... broad range of topics will be presented as scientists ...
(Date:9/21/2014)... global warming, are set to rise again in 2014 - ... 2.5 per cent projected rise in burning fossil fuels is ... the UK by researchers at the Tyndall Centre for Climate ... College of Engineering, Mathematics and Physical Sciences at the University ... Climate Summit, where world leaders will seek to catalyse action ...
(Date:9/21/2014)... MA -- Shellfish such as mussels and barnacles secrete ... or ship hulls, even underwater. Inspired by these natural ... materials that could be used to repair ships or ... their new waterproof adhesives, the MIT researchers engineered bacteria ... mussel proteins as well as a bacterial protein found ...
Breaking Biology News(10 mins):Geoscience topics in the spotlight -- Vancouver, BC 2Geoscience topics in the spotlight -- Vancouver, BC 3Geoscience topics in the spotlight -- Vancouver, BC 4Geoscience topics in the spotlight -- Vancouver, BC 5CO2 emissions set to reach new 40 billion ton record high in 2014 2CO2 emissions set to reach new 40 billion ton record high in 2014 3Engineered proteins stick like glue -- even in water 2Engineered proteins stick like glue -- even in water 3
... /PRNewswire-iReach/ -- Industry leader in healthcare operations decision ... the family waiting room experience.  While PatientStream,s electronic ... now offers a customizable multilingual whiteboard that can ... 3o languages are currently available, with more being ...
... antibiotic resistance correlates with oral ingestion of antibiotics, raising the ... of resistance. The manuscript appears online ahead of print ... "For more than 40 years, a few doses of ... says Hua Wang of the Ohio State University, Columbus, a ...
... to Research Careers) Program has announced the travel award ... MA from July 20-24, 2013. These awards are meant ... from underrepresented groups into the mainstream of the basic ... scientists at the 27th Protein Society Symposium. Awards ...
Cached Biology News:PatientStream announces the industry's first Multilingual family waiting room board 2PatientStream announces the industry's first Multilingual family waiting room board 3Antibiotics: Change route of delivery to mitigate resistance 2
... number of modifications of Grace's medium were ... 1960's and 1970's. Many of these modifications ... the growth of cells derived from the ... modification known as TNM-FH. The medium when ...
... optically clear polystyrene with frosted labeling ... for cell counting. 100% integrity tested. ... new product number, created to easily ... no availability yet, please order under ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Biology Products: